C07C 327/22
Having carbon atoms of esterified thiocarboxyl groups bound to hydrogen atoms or
Official title: having carbon atoms of esterified thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
C07C327/22 (Having carbon atoms of esterified thiocarboxyl groups bound to hydrogen atoms or) appears on 213 US grants and 147 published applications in this corpus.
Search patents in C07C- Granted patents
- 213
- Published applications
- 147
- Assignees
- 147
- Inventors
- 534
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 5 | 0 |
| 1981 | 5 | 0 |
| 1982 | 5 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 5 | 0 |
| 1992 | 7 | 0 |
| 1993 | 10 | 0 |
| 1994 | 5 | 0 |
| 1995 | 6 | 0 |
| 1996 | 7 | 0 |
| 1997 | 4 | 0 |
| 1998 | 4 | 0 |
| 1999 | 6 | 0 |
| 2000 | 4 | 0 |
| 2001 | 10 | 1 |
| 2002 | 3 | 3 |
| 2003 | 9 | 6 |
| 2004 | 3 | 9 |
| 2005 | 3 | 8 |
| 2006 | 3 | 4 |
| 2007 | 6 | 5 |
| 2008 | 5 | 5 |
| 2009 | 3 | 7 |
| 2010 | 10 | 2 |
| 2011 | 4 | 4 |
| 2012 | 0 | 6 |
| 2013 | 2 | 6 |
| 2014 | 9 | 5 |
| 2015 | 6 | 2 |
| 2016 | 1 | 9 |
| 2017 | 5 | 1 |
| 2018 | 4 | 4 |
| 2019 | 5 | 5 |
| 2020 | 3 | 5 |
| 2021 | 7 | 5 |
| 2022 | 5 | 15 |
| 2023 | 6 | 8 |
| 2024 | 5 | 11 |
| 2025 | 6 | 8 |
| 2026 | 3 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Rapidly metabolized lipid compound5 May 2026US 12,617,752 B2Beijing Jitai Life Sciences Ltd
- Synthetic methods using native chemical ligation in flow14 Apr 2026US 12,600,746 B2The University of Sydney
- Methods and materials for modulating Nrf2 pathway13 Jan 2026US 12,521,439 B2President and Fellows of Harvard College
- Analogues of oleuropein and oleacein and uses thereof16 Sep 2025US 12,414,960 B2Attica Sciences Ltd.
- Biodegradable lipids for the delivery of active agents22 Jul 2025US 12,364,762 B2Alnylam Pharmaceuticals, Inc.
- Rapidly metabolized lipid compound9 Jul 2026US 2026/0193167 A1Beijing Jitai Life Sciences Ltd
- Methods and materials for modulating nrf2 pathway7 May 2026US 2026/0124310 A1President and Fellows of Harvard College
- Fluorination process12 Feb 2026US 2026/0042715 A1Royal College of Surgeons In Ireland
- Curable composition, cured product, optical material, diffractive optical element, and compound18 Dec 2025US 2025/0382406 A1FUJIFILM Corporation
- Compound, additive, plasticizer, curable composition, adhesive, cured product, and pressure-sensitive adhesive11 Dec 2025US 2025/0376606 A1Mitsui Chemicals, Inc.
Most cited
By later US patents
- Antioxidants67US 6,664,287 B2Bethesda Pharmaceuticals, Inc. · 2003
- Fatty-acid amide hydrolase62US 6,271,015 B1The Scripps Research Institute · 2001
- .alpha.-substituted phenylacetic acid derivative, its production and agricultural fungicide containing it61US 5,948,819 AShionogi & Co., Ltd. · 1999
- O-benzyloxime ethers and crop protection agents containing these compounds47US 5,194,662 ABASF SE · 1993
- Amide compounds and use of the same40US 6,174,887 B1Japan Tobacco Inc. · 2001